Avaliação das moléculas HLA-G e PD-L1 em pacientes submetidos a transplante renal em Goiânia - GO

Detalhes bibliográficos
Autor(a) principal: Botelho, Silvia Marçal
Data de Publicação: 2020
Tipo de documento: Tese
Idioma: por
Título da fonte: Repositório Institucional da UFG
dARK ID: ark:/38995/00130000020t1
Texto Completo: http://repositorio.bc.ufg.br/tede/handle/tede/11702
Resumo: Kidney transplantation (KT) is the treatment of choice for patients with end-stage renal disease. In KT, the HLA-G and PD-L1 molecules due to their tolerogenic action are of clinical and therapeutic interest. The aim of this study was to evaluate the HLA-G and PD-L1 molecules at different moments in the KT. 124 patients were evaluated. Of these, 114 were previously transplanted (Group of old patients-GOP) and, in 10 patients, the evaluation started in the pre-KT (Group of new patients-GNP). In the GOP a cross-sectional study with a single blood collection, while in the GPN a 12-month follow-up was carried out with serial blood collection. Patients who had graft dysfunction were submitted to renal biopsy samples and immunohistochemistry was performed for both molecules (GNP). The study execution phase took place from March/2016 to December/2017. In GOP the use of corticosteroids+calcineurin inhibitor +azathioprine as an initial immunosuppression regimen (p<0,001), the presence of one or two episodes of rejection (p <0,001), and CMV infection (p= ,006) were correlated with a low dosage of HLA-G. Having performed 6-10 hemodialysis sessions in post-KT was associated with a high dose of HLA-G (p=0,02). In GNP the occurrence of rejection episodes was associated with low expression of HLA-G (p<0,001) and PD-L1 (p<0,001). The variable time after KT (p<0,001) was associated with a lower level of HLA-G. Transfused patients had low levels of PD-L1 (p=0,03). Increased levels of HLA-G (p=0,001) and PD-L1 (p<0,001) were observed in female patients. Patients who received a kidney from a related live donor expressed more HLA-G (p<0,001). The study concluded that the aforementioned variables, which were positively and negatively associated with the levels of HLA-G and PD-L1 can promote the stability or instability of the grafts respectively, maintaining renal function or perhaps providing rejection processes.
id UFG-2_a2b95db694cb30593f721e81a05da266
oai_identifier_str oai:repositorio.bc.ufg.br:tede/11702
network_acronym_str UFG-2
network_name_str Repositório Institucional da UFG
repository_id_str
spelling Silva, Nilzio Antonio dahttp://lattes.cnpq.br/1780564621664455Wastowski, Isabela Jubéhttp://lattes.cnpq.br/4051434704701413Wastowski, Isabela JubéReis, Ângela Adamski da SilvaBarbosa, Maria AlvesSousa, Mauri Félix deBarbosa, Vitalina de Souzahttp://lattes.cnpq.br/8853814788637163Botelho, Silvia Marçal2021-10-28T12:01:32Z2021-10-28T12:01:32Z2020-09-11BOTELHO, S. M. Avaliação das moléculas HLA-G e PD-L1 em pacientes submetidos a transplante renal em Goiânia - GO. 2020. 138 f. Tese (Doutorado em Ciências da Saúde) - Universidade Federal de Goiás, Goiânia, 2020.http://repositorio.bc.ufg.br/tede/handle/tede/11702ark:/38995/00130000020t1Kidney transplantation (KT) is the treatment of choice for patients with end-stage renal disease. In KT, the HLA-G and PD-L1 molecules due to their tolerogenic action are of clinical and therapeutic interest. The aim of this study was to evaluate the HLA-G and PD-L1 molecules at different moments in the KT. 124 patients were evaluated. Of these, 114 were previously transplanted (Group of old patients-GOP) and, in 10 patients, the evaluation started in the pre-KT (Group of new patients-GNP). In the GOP a cross-sectional study with a single blood collection, while in the GPN a 12-month follow-up was carried out with serial blood collection. Patients who had graft dysfunction were submitted to renal biopsy samples and immunohistochemistry was performed for both molecules (GNP). The study execution phase took place from March/2016 to December/2017. In GOP the use of corticosteroids+calcineurin inhibitor +azathioprine as an initial immunosuppression regimen (p<0,001), the presence of one or two episodes of rejection (p <0,001), and CMV infection (p= ,006) were correlated with a low dosage of HLA-G. Having performed 6-10 hemodialysis sessions in post-KT was associated with a high dose of HLA-G (p=0,02). In GNP the occurrence of rejection episodes was associated with low expression of HLA-G (p<0,001) and PD-L1 (p<0,001). The variable time after KT (p<0,001) was associated with a lower level of HLA-G. Transfused patients had low levels of PD-L1 (p=0,03). Increased levels of HLA-G (p=0,001) and PD-L1 (p<0,001) were observed in female patients. Patients who received a kidney from a related live donor expressed more HLA-G (p<0,001). The study concluded that the aforementioned variables, which were positively and negatively associated with the levels of HLA-G and PD-L1 can promote the stability or instability of the grafts respectively, maintaining renal function or perhaps providing rejection processes.O transplante renal (TR) é o tratamento de escolha para pacientes com doença renal crônica terminal. No TR, as moléculas HLA-G e PD-L1, por sua ação tolerogênica, são de interesse clínico e terapêutico. O objetivo deste estudo foi avaliar as moléculas HLA-G e PD-L1 em diferentes momentos do TR. Foram avaliados 124 pacientes. Destes, 114 eram previamente transplantados (Grupo de pacientes antigos-GPA) e, em 10 pacientes, a avaliação iniciou-se no pré-TR (Grupo de pacientes novos-GPN). No GPA, estudo transversal com coleta única de sangue, enquanto, no GPN foi realizado um follow-up de 12 meses, com coleta de sangue seriada. Pacientes que tiveram disfunção do enxerto, foram submetidos a coleta de biópsias renais e realizada imuno-histoquímica para ambas as moléculas (GPN). A fase de execução do estudo ocorreu de março/2016 a dezembro/2017. No GPA, o uso de corticoide+inibidor calcineurina+azatioprina como esquema de imunossupressão inicial (p<0,001), presença de um ou dois episódios de rejeição (p<0,001) e infecção por CMV(p=0,006) se correlacionaram com baixa dosagem de HLA-G. Ter realizado de 6-10 sessões de hemodiálise no pós-TR renal associou-se a uma elevada dosagem de HLA-G (p=0,02). No GPN, a ocorrência de episódios de rejeição foi associada a baixa expressão de HLA-G (p<0,001) e PD-L1 (p<0,001). A variável tempo pós-TR (p<0,001) esteve associada a menor nível de HLA-G. Pacientes transfundidos apresentaram baixos níveis de PD-L1 (p=0,03). Níveis aumentados de HLA-G (p=0,001) e PD-L1 (p<0,001) foram observados em pacientes do sexo feminino. Os pacientes que receberam rim de doador vivo relacionado expressaram mais HLA-G (p<0,001). O estudo concluiu que as variáveis supracitadas, que estiveram associadas positiva e negativamente com os níveis de HLA-G e PD-L1, podem promover a estabilidade ou instabilidade dos enxertos respectivamente, mantendo a função renal ou propiciando talvez processos de rejeiçãoSubmitted by Marlene Santos (marlene.bc.ufg@gmail.com) on 2021-10-28T03:28:36Z No. of bitstreams: 2 Tese - Silvia Marçal Botelho - 2020.pdf: 3566768 bytes, checksum: 4ad9ed96a1fd1a4e61b9b1451e0ebd29 (MD5) license_rdf: 805 bytes, checksum: 4460e5956bc1d1639be9ae6146a50347 (MD5)Approved for entry into archive by Luciana Ferreira (lucgeral@gmail.com) on 2021-10-28T12:01:31Z (GMT) No. of bitstreams: 2 Tese - Silvia Marçal Botelho - 2020.pdf: 3566768 bytes, checksum: 4ad9ed96a1fd1a4e61b9b1451e0ebd29 (MD5) license_rdf: 805 bytes, checksum: 4460e5956bc1d1639be9ae6146a50347 (MD5)Made available in DSpace on 2021-10-28T12:01:32Z (GMT). No. of bitstreams: 2 Tese - Silvia Marçal Botelho - 2020.pdf: 3566768 bytes, checksum: 4ad9ed96a1fd1a4e61b9b1451e0ebd29 (MD5) license_rdf: 805 bytes, checksum: 4460e5956bc1d1639be9ae6146a50347 (MD5) Previous issue date: 2020-09-11OutroporUniversidade Federal de GoiásPrograma de Pós-graduação em Ciências da Saúde (FM)UFGBrasilFaculdade de Medicina - FM (RG)Attribution-NonCommercial-NoDerivatives 4.0 Internationalhttp://creativecommons.org/licenses/by-nc-nd/4.0/info:eu-repo/semantics/openAccessHLA-GPD-L1Transplante renalRejeiçãoKidney transplantationRejectionCIENCIAS DA SAUDEAvaliação das moléculas HLA-G e PD-L1 em pacientes submetidos a transplante renal em Goiânia - GOEvaluation of HLA-G and PD-L1 molecules in patients submitted to kidney transplantation in Goiânia - GOinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/doctoralThesis25500500500500191825reponame:Repositório Institucional da UFGinstname:Universidade Federal de Goiás (UFG)instacron:UFGLICENSElicense.txtlicense.txttext/plain; charset=utf-81748http://repositorio.bc.ufg.br/tede/bitstreams/c8e8c726-e162-4f77-addf-29a12fba6165/download8a4605be74aa9ea9d79846c1fba20a33MD51ORIGINALTese - Silvia Marçal Botelho - 2020.pdfTese - Silvia Marçal Botelho - 2020.pdfapplication/pdf3566768http://repositorio.bc.ufg.br/tede/bitstreams/8932c7bf-26d9-47d9-9ed6-bd701a6b4c86/download4ad9ed96a1fd1a4e61b9b1451e0ebd29MD53CC-LICENSElicense_rdflicense_rdfapplication/rdf+xml; charset=utf-8805http://repositorio.bc.ufg.br/tede/bitstreams/7bdf764c-1bc8-4866-bacc-2227fc81f76d/download4460e5956bc1d1639be9ae6146a50347MD52tede/117022021-10-28 09:01:32.232http://creativecommons.org/licenses/by-nc-nd/4.0/Attribution-NonCommercial-NoDerivatives 4.0 Internationalopen.accessoai:repositorio.bc.ufg.br:tede/11702http://repositorio.bc.ufg.br/tedeRepositório InstitucionalPUBhttp://repositorio.bc.ufg.br/oai/requesttasesdissertacoes.bc@ufg.bropendoar:2021-10-28T12:01:32Repositório Institucional da UFG - Universidade Federal de Goiás (UFG)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
dc.title.pt_BR.fl_str_mv Avaliação das moléculas HLA-G e PD-L1 em pacientes submetidos a transplante renal em Goiânia - GO
dc.title.alternative.eng.fl_str_mv Evaluation of HLA-G and PD-L1 molecules in patients submitted to kidney transplantation in Goiânia - GO
title Avaliação das moléculas HLA-G e PD-L1 em pacientes submetidos a transplante renal em Goiânia - GO
spellingShingle Avaliação das moléculas HLA-G e PD-L1 em pacientes submetidos a transplante renal em Goiânia - GO
Botelho, Silvia Marçal
HLA-G
PD-L1
Transplante renal
Rejeição
Kidney transplantation
Rejection
CIENCIAS DA SAUDE
title_short Avaliação das moléculas HLA-G e PD-L1 em pacientes submetidos a transplante renal em Goiânia - GO
title_full Avaliação das moléculas HLA-G e PD-L1 em pacientes submetidos a transplante renal em Goiânia - GO
title_fullStr Avaliação das moléculas HLA-G e PD-L1 em pacientes submetidos a transplante renal em Goiânia - GO
title_full_unstemmed Avaliação das moléculas HLA-G e PD-L1 em pacientes submetidos a transplante renal em Goiânia - GO
title_sort Avaliação das moléculas HLA-G e PD-L1 em pacientes submetidos a transplante renal em Goiânia - GO
author Botelho, Silvia Marçal
author_facet Botelho, Silvia Marçal
author_role author
dc.contributor.advisor1.fl_str_mv Silva, Nilzio Antonio da
dc.contributor.advisor1Lattes.fl_str_mv http://lattes.cnpq.br/1780564621664455
dc.contributor.advisor-co1.fl_str_mv Wastowski, Isabela Jubé
dc.contributor.advisor-co1Lattes.fl_str_mv http://lattes.cnpq.br/4051434704701413
dc.contributor.referee1.fl_str_mv Wastowski, Isabela Jubé
dc.contributor.referee2.fl_str_mv Reis, Ângela Adamski da Silva
dc.contributor.referee3.fl_str_mv Barbosa, Maria Alves
dc.contributor.referee4.fl_str_mv Sousa, Mauri Félix de
dc.contributor.referee5.fl_str_mv Barbosa, Vitalina de Souza
dc.contributor.authorLattes.fl_str_mv http://lattes.cnpq.br/8853814788637163
dc.contributor.author.fl_str_mv Botelho, Silvia Marçal
contributor_str_mv Silva, Nilzio Antonio da
Wastowski, Isabela Jubé
Wastowski, Isabela Jubé
Reis, Ângela Adamski da Silva
Barbosa, Maria Alves
Sousa, Mauri Félix de
Barbosa, Vitalina de Souza
dc.subject.por.fl_str_mv HLA-G
PD-L1
Transplante renal
Rejeição
topic HLA-G
PD-L1
Transplante renal
Rejeição
Kidney transplantation
Rejection
CIENCIAS DA SAUDE
dc.subject.eng.fl_str_mv Kidney transplantation
Rejection
dc.subject.cnpq.fl_str_mv CIENCIAS DA SAUDE
description Kidney transplantation (KT) is the treatment of choice for patients with end-stage renal disease. In KT, the HLA-G and PD-L1 molecules due to their tolerogenic action are of clinical and therapeutic interest. The aim of this study was to evaluate the HLA-G and PD-L1 molecules at different moments in the KT. 124 patients were evaluated. Of these, 114 were previously transplanted (Group of old patients-GOP) and, in 10 patients, the evaluation started in the pre-KT (Group of new patients-GNP). In the GOP a cross-sectional study with a single blood collection, while in the GPN a 12-month follow-up was carried out with serial blood collection. Patients who had graft dysfunction were submitted to renal biopsy samples and immunohistochemistry was performed for both molecules (GNP). The study execution phase took place from March/2016 to December/2017. In GOP the use of corticosteroids+calcineurin inhibitor +azathioprine as an initial immunosuppression regimen (p<0,001), the presence of one or two episodes of rejection (p <0,001), and CMV infection (p= ,006) were correlated with a low dosage of HLA-G. Having performed 6-10 hemodialysis sessions in post-KT was associated with a high dose of HLA-G (p=0,02). In GNP the occurrence of rejection episodes was associated with low expression of HLA-G (p<0,001) and PD-L1 (p<0,001). The variable time after KT (p<0,001) was associated with a lower level of HLA-G. Transfused patients had low levels of PD-L1 (p=0,03). Increased levels of HLA-G (p=0,001) and PD-L1 (p<0,001) were observed in female patients. Patients who received a kidney from a related live donor expressed more HLA-G (p<0,001). The study concluded that the aforementioned variables, which were positively and negatively associated with the levels of HLA-G and PD-L1 can promote the stability or instability of the grafts respectively, maintaining renal function or perhaps providing rejection processes.
publishDate 2020
dc.date.issued.fl_str_mv 2020-09-11
dc.date.accessioned.fl_str_mv 2021-10-28T12:01:32Z
dc.date.available.fl_str_mv 2021-10-28T12:01:32Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/doctoralThesis
format doctoralThesis
status_str publishedVersion
dc.identifier.citation.fl_str_mv BOTELHO, S. M. Avaliação das moléculas HLA-G e PD-L1 em pacientes submetidos a transplante renal em Goiânia - GO. 2020. 138 f. Tese (Doutorado em Ciências da Saúde) - Universidade Federal de Goiás, Goiânia, 2020.
dc.identifier.uri.fl_str_mv http://repositorio.bc.ufg.br/tede/handle/tede/11702
dc.identifier.dark.fl_str_mv ark:/38995/00130000020t1
identifier_str_mv BOTELHO, S. M. Avaliação das moléculas HLA-G e PD-L1 em pacientes submetidos a transplante renal em Goiânia - GO. 2020. 138 f. Tese (Doutorado em Ciências da Saúde) - Universidade Federal de Goiás, Goiânia, 2020.
ark:/38995/00130000020t1
url http://repositorio.bc.ufg.br/tede/handle/tede/11702
dc.language.iso.fl_str_mv por
language por
dc.relation.program.fl_str_mv 25
dc.relation.confidence.fl_str_mv 500
500
500
500
dc.relation.department.fl_str_mv 19
dc.relation.cnpq.fl_str_mv 182
dc.relation.sponsorship.fl_str_mv 5
dc.rights.driver.fl_str_mv Attribution-NonCommercial-NoDerivatives 4.0 International
http://creativecommons.org/licenses/by-nc-nd/4.0/
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Attribution-NonCommercial-NoDerivatives 4.0 International
http://creativecommons.org/licenses/by-nc-nd/4.0/
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Universidade Federal de Goiás
dc.publisher.program.fl_str_mv Programa de Pós-graduação em Ciências da Saúde (FM)
dc.publisher.initials.fl_str_mv UFG
dc.publisher.country.fl_str_mv Brasil
dc.publisher.department.fl_str_mv Faculdade de Medicina - FM (RG)
publisher.none.fl_str_mv Universidade Federal de Goiás
dc.source.none.fl_str_mv reponame:Repositório Institucional da UFG
instname:Universidade Federal de Goiás (UFG)
instacron:UFG
instname_str Universidade Federal de Goiás (UFG)
instacron_str UFG
institution UFG
reponame_str Repositório Institucional da UFG
collection Repositório Institucional da UFG
bitstream.url.fl_str_mv http://repositorio.bc.ufg.br/tede/bitstreams/c8e8c726-e162-4f77-addf-29a12fba6165/download
http://repositorio.bc.ufg.br/tede/bitstreams/8932c7bf-26d9-47d9-9ed6-bd701a6b4c86/download
http://repositorio.bc.ufg.br/tede/bitstreams/7bdf764c-1bc8-4866-bacc-2227fc81f76d/download
bitstream.checksum.fl_str_mv 8a4605be74aa9ea9d79846c1fba20a33
4ad9ed96a1fd1a4e61b9b1451e0ebd29
4460e5956bc1d1639be9ae6146a50347
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositório Institucional da UFG - Universidade Federal de Goiás (UFG)
repository.mail.fl_str_mv tasesdissertacoes.bc@ufg.br
_version_ 1815172530194874368